Ohio Public Employees Retirement System (OPERS)’s Spyre Therapeutics SYRE Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio SYRE Stock Details SYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-328	Closed	-$19K	–	2037
2022 Q1	$19K	Buy	328 +172	+110%	+$14.4K	﹤0.01%	1944
2021 Q4	$18K	Buy	+156	New	+$24.6K	﹤0.01%	1959
2020 Q2	–	Sell	-15	Closed	-$2K	–	1942
2020 Q1	$2K	Buy	+15	New	+$2.55K	﹤0.01%	1874
2019 Q3	–	Sell	-156	Closed	-$27K	–	1972
2019 Q2	$27K	Buy	+156	New	+$27K	﹤0.01%	1888

Other funds holding SYRE

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s SYRE Position: Q2 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Spyre Therapeutics (SYRE) in Q2 2022, closing a stake of 328 shares — an estimated $19K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in SYRE in Q2 2019 and held it in 4 quarters. The position peaked at $27K in Q2 2019. 66 funds tracked by Wall St. Rank hold SYRE as of Q2 2022.

Ohio Public Employees Retirement System (OPERS) reported no remaining Spyre Therapeutics position as of Q2 2022 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 328 Spyre Therapeutics shares in Q2 2022, an estimated $19K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Spyre Therapeutics in Q2 2019 and held it in 4 quarters.
Ohio Public Employees Retirement System (OPERS)'s Spyre Therapeutics position peaked at $27K in Q2 2019.
66 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2022, filed 15 Aug 2022.